🔎 Trials Near Me

Почетна › Рак дојке › Kentaki › Louisville

Kliničke studije za Рак дојке u gradu Louisville, KY

10 studija za Рак дојке traži učesnike na lokacijama u gradu Louisville i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Тражи се учесникФаза 3
  • Norton Cancer Institute, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT05696626

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Тражи се учесникФаза 3
  • University of Louisville Hospital, Louisville
  • Baptist Health Louisville, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

Тражи се учесникФаза 3
  • Baptist Health Floyd, New Albany · 4 ми удаљено
Узраст од 18 до 50 · Оба пола · Ажурирано 4. 11. 2026. · NCT06748222

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • Baptist Health Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
  • и још 1
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Тражи се учесникФаза 3
  • University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07173751

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Тражи се учесникОпсервациона студија
  • Norton Cancer Institute - Downtown, Louisville
  • Baptist Health Louisville, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06401421

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Тражи се учесникФаза 3
  • Research Site, Louisville
Узраст од 18 до 130 · Оба пола · Ажурирано 19. 10. 2026. · NCT07647328

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Тражи се учесникФаза 3
  • University Medical Center, Inc. ; DBA UofL Health - UofL Hospital/Brown Cancer Center, Louisville
  • UofL Health Brown Cancer Center Medical Center Northeast, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965

EXoPERT EMERALD Clinical Study

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • KCTL, Louisville
Узраст 45 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT07186296

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

Тражи се учесникФаза 2
  • James Graham Brown Cancer Center, Louisville
Узраст 18 и старији · Жене · Ажурирано 20. 2. 2025. · NCT04990921

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu Louisville

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.